Ç×Ä۽õãÁ¦ ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Anticoccidial Drug Market Report: Trends, Forecast and Competitive Analysis to 2031
»óǰÄÚµå : 1680335
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,850 £Ü 5,274,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,370,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,350 £Ü 7,330,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,050 £Ü 9,659,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Ç×Ä۽õãÁ¦ ½ÃÀåÀÇ ¹Ì·¡´Â µ¿¹°º´¿ø°ú ¼Ò¸Å ¾à±¹ ½ÃÀå¿¡ ±âȸ°¡ ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¼¼°è Ç×Ä۽õãÁ¦ ½ÃÀåÀº 2025³âºÎÅÍ 2031³â±îÁö CAGR 5.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº Ä۽õãÁõ À¯º´·ü Áõ°¡, ¼öÀÇÇÐ ¹ßÀü, À°·ù ¹× °¡±Ý·ù Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù.

Ç×Ä۽õãÁ¦ ½ÃÀåÀÇ Àü·«Àû ¼ºÀå ±âȸ

Ç×Ä۽õãÁ¦ ½ÃÀåÀº ´Ü¹éÁú ¼ö¿ä Áõ°¡·Î ÀÎÇÑ ¼¼°è °¡±Ý·ù »ý»ê·® Áõ°¡·Î ÀÎÇØ Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¿ªµ¿ÀûÀΠȯ°æÀº ¾÷°è °ü°èÀڵ鿡°Ô ¸¹Àº Àü·«Àû ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. Á¦Çü Çõ½Å, Áö¼Ó°¡´ÉÇÑ °üÇàÀ¸·ÎÀÇ Àüȯ, µ¿¹° º¹Áö¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¿ªÇÐÀÌ ÀçÆíµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Ȱ¿ëÇÔÀ¸·Î½á ±â¾÷Àº ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­Çϰí ÁøÈ­ÇÏ´Â °í°´ ´ÏÁî¿¡ ´ëÀÀÇÒ ¼ö Àֱ⠶§¹®¿¡ Àü·«Àû ¼ºÀå ±âȸ¸¦ ½Äº°Çϰí Ãß±¸ÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.

Ç×Ä۽õãÁ¦ ½ÃÀå¿¡´Â ½ÅÈï ½ÃÀå ÁøÃâ, »õ·Î¿î Á¦Çü °³¹ß, ¿¹¹æ À§»ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÁýÁß, ±â¼ú Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞ, Áö¼Ó°¡´ÉÇÑ Á¦Ç° °³¹ß µî ¸î °¡Áö Àü·«Àû ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö´ÜÀ» Ãß±¸ÇÔÀ¸·Î½á ±â¾÷Àº °æÀï·ÂÀ» °­È­Çϰí, ÁøÈ­ÇÏ´Â ½ÃÀå ¿ä±¸¿¡ ´ëÀÀÇϸç, ºü¸£°Ô º¯È­ÇÏ´Â ¾÷°è¿¡¼­ È®°íÇÑ ÀÔÁö¸¦ È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Ç×Ä۽õãÁ¦ ½ÃÀå ÃËÁø¿äÀÎ ¹× °úÁ¦

Ç×Ä۽õãÁ¦ ½ÃÀåÀº »ý»ê °üÇà°ú ¼ÒºñÀÚ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ Å« º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è °¡±Ý·ù ¼Òºñ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Ä۽õãÁõ¿¡ ´ëÇÑ È¿°úÀûÀÎ ÇØ°áÃ¥¿¡ ´ëÇÑ Çʿ伺ÀÌ Á¡Á¡ ´õ Ä¿Áö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ±ÔÁ¦ ¾Ð·Â°ú ¼ÒºñÀÚ ¼±È£µµ º¯È­¶ó´Â µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌÇØ°ü°èÀÚµéÀÌ ÀÌ·¯ÇÑ º¹ÀâÇÑ »óȲÀ» ±Øº¹ÇÏ°í ¼ºÀå ±âȸ¸¦ Ȱ¿ëÇϱâ À§Çؼ­´Â ÃËÁø¿äÀΰú µµÀü °úÁ¦¸¦ ¸ðµÎ ÀÌÇØÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.

Ç×Ä۽õãÁ¦ ½ÃÀåÀ» À̲ô´Â ¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù:

Ç×Ä۽õãÁ¦ ½ÃÀåÀÇ °úÁ¦´Â ´ÙÀ½°ú °°½À´Ï´Ù:

°á·ÐÀûÀ¸·Î, Ç×Ä۽õãÁ¦ ½ÃÀåÀº ´ß°í±â »ý»ê·® Áõ°¡, µ¿¹° °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ´ëüǰ¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø, ±â¼ú ¹ßÀü, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ±ÔÁ¦Àû Àå¾Ö¹°, ½ÃÀå Æ÷È­, ¼ÒºñÀÚ ¼±È£µµ º¯È­ µî ¿©·¯ °¡Áö µµÀü°úÁ¦¸¦ ÇØ°áÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇÐÀ» ÀÌÇØÇϸé ÀÌÇØ°ü°èÀÚµéÀÌ ½ÃÀåÀÇ º¹À⼺À» ±Øº¹ÇÏ°í ¼ºÀå ±âȸ¸¦ Æ÷ÂøÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ Ç×Ä۽õãÁ¦ ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå 2019³âºÎÅÍ 2031³â±îÁö ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦4Àå 2019³âºÎÅÍ 2031³â±îÁö ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼® : Áö¿ªº°

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·« ºÐ¼®

Á¦7Àå ÁÖ¿ä ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The future of the global anticoccidial drug market looks promising with opportunities in the veterinary hospital and retail pharmacy markets. The global anticoccidial drug market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of coccidiosis, growing developments in veterinary medicine, and expanding demand for meat and poultry products.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Anticoccidial Drug Market

The anticoccidial drug market is evolving rapidly, responding to the growing demand for poultry products and increasing concerns about drug resistance and animal welfare. Innovations in formulations and a shift toward sustainable practices are shaping this market. Regulatory changes and consumer preferences are also driving the development of alternative therapies and natural products. As stakeholders adapt to these challenges, several emerging trends are becoming prominent in the anticoccidial landscape.

The anticoccidial drug market is undergoing transformative changes characterized by a move toward natural products, innovative formulations, increased research investment, a focus on animal welfare, and evolving regulatory landscapes. These trends not only address current market demands but also pave the way for a more sustainable and effective approach to managing coccidiosis in livestock.

Recent Developments in the Anticoccidial Drug Market

The anticoccidial drug market is evolving in response to growing challenges such as antibiotic resistance, changing consumer preferences, and stricter regulations. Key players are investing in research and development to create more effective and sustainable solutions. As the demand for poultry products increases globally, advancements in formulations and a focus on animal welfare are shaping the landscape. Understanding these recent developments is crucial for stakeholders aiming to navigate the complexities of the market and adapt to emerging trends.

The anticoccidial drug market is experiencing significant developments marked by new drug approvals, enhanced combination therapies, a focus on resistance management, the integration of technology, and an emphasis on sustainable practices. These advancements not only respond to current challenges but also position the industry for future growth, ultimately benefiting producers and consumers alike.

Strategic Growth Opportunities for Anticoccidial Drug Market

The anticoccidial drug market is poised for significant growth as global poultry production continues to rise, driven by increasing protein demand. This dynamic landscape presents numerous strategic opportunities for industry players. Innovations in formulations, a shift toward sustainable practices, and growing consumer awareness about animal welfare are reshaping market dynamics. By capitalizing on these trends, companies can enhance their market position and meet evolving customer needs, making it essential to identify and pursue strategic growth opportunities.

The anticoccidial drug market presents several strategic growth opportunities, including expansion into emerging markets, the development of novel formulations, a focus on preventive health solutions, collaboration with technology providers, and sustainable product development. By pursuing these avenues, companies can enhance their competitive edge, respond to evolving market needs, and secure a robust position in this rapidly changing industry.

Anticoccidial Drug Market Driver and Challenges

The anticoccidial drug market is experiencing significant transformation, driven by various factors that influence production practices and consumer demand. As global poultry consumption rises, the need for effective solutions to combat coccidiosis becomes increasingly critical. However, this market also faces challenges such as regulatory pressures and shifting consumer preferences. Understanding both the drivers and challenges is essential for stakeholders aiming to navigate the complexities of this evolving landscape and capitalize on growth opportunities.

The factors responsible for driving the anticoccidial drug market include:

Challenges in the anticoccidial drug market are:

In conclusion, the anticoccidial drug market is driven by rising poultry production, growing awareness of animal health, regulatory support for alternatives, technological advancements, and increased investment in R&D. However, challenges such as regulatory hurdles, market saturation, and shifting consumer preferences must be addressed. Understanding these dynamics will help stakeholders navigate the complexities of the market and seize growth opportunities.

List of Anticoccidial Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies anticoccidial drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoccidial drug companies profiled in this report include-

Anticoccidial Drug by Segment

The study includes a forecast for the global anticoccidial drug market by animal, drug action, drug class, distribution channel, and region.

Anticoccidial Drug Market by Animal [Analysis by Value from 2019 to 2031]:

Anticoccidial Drug Market by Drug Action [Analysis by Value from 2019 to 2031]:

Anticoccidial Drug Market by Drug Class [Analysis by Value from 2019 to 2031]:

Anticoccidial Drug Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

Anticoccidial Drug Market by Region [Analysis by Value from 2019 to 2031]:

Country Wise Outlook for the Anticoccidial Drug Market

The anticoccidial drug market is witnessing significant advancements driven by increasing poultry production, rising awareness of animal health, and regulatory changes. Key players are focusing on innovative formulations and alternative therapies to combat drug resistance and improve efficacy. Countries like the United States, China, Germany, India, and Japan are experiencing varied developments influenced by local market demands, regulatory frameworks, and agricultural practices. Understanding these regional dynamics can provide insights into the ultimate trajectory of the global anticoccidial market.

Features of the Global Anticoccidial Drug Market

Market Size Estimates: Anticoccidial drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Anticoccidial drug market size by various segments, such as by animal, drug action, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Anticoccidial drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different animals, drug actions, drug classes, distribution channels, and regions for the anticoccidial drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoccidial drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Anticoccidial Drug Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2019 to 2031

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â